|
1.
|
Sato N, Funayama N, Nagafuchi A, Yonemura
S and Tsukita S: A gene family consisting of ezrin, radixin and
moesin. Its specific localization at actin filament/plasma membrane
association sites. J Cell Sci. 103:131–143. 1992.
|
|
2.
|
Pataky F, Pironkova R and Hudspeth AJ:
Radixin is a constituent of stereocilia in hair cells. Proc Natl
Acad Sci USA. 101:2601–2606. 2004.
|
|
3.
|
Faure S, Salazar-Fontana LI, Semichon M,
Tybulewicz VL, Bismuth G, Trautmann A, Germain RN and Delon J: ERM
proteins regulate cytoskeleton relaxation promoting T cell-APC
conjugation. Nat Immunol. 5:272–279. 2004.
|
|
4.
|
Vaheri A, Carpén O, Heiska L, Helander TS,
Jääskeläinen J, Majander-Nordenswan P, Sainio M, Timonen T and
Turunen O: The ezrin protein family: membrane-cytoskeleton
interactions and disease associations. Curr Opin Cell Biol.
9:659–666. 1997.
|
|
5.
|
Hiscox S and Jiang WG: Ezrin regulates
cell-cell and cell-matrix adhesion, a possible role with
E-cadherin/β-catenin. J Cell Sci. 112:3081–3090. 1999.
|
|
6.
|
Mhawech-Fauceglia P, Dulguerov P, Beck A,
Bonet M and Allal AS: Value of ezrin, maspin and nm23-H1 protein
expressions in predicting outcome of patients with head and neck
squamous-cell carcinoma treated with radical radiotherapy. J Clin
Pathol. 60:185–189. 2007.
|
|
7.
|
Valdman A, Fang X, Pang ST, Nilsson B,
Ekman P and Egevad L: Ezrin expression in prostate cancer and
benign prostatic tissue. Eur Urol. 48:852–857. 2005.
|
|
8.
|
Weng WH, Ahlen J, Astrom K, Lui WO and
Larsson C: Prognostic impact of immunohistochemical expression of
ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res.
11:6198–6204. 2005.
|
|
9.
|
Bruce B, Khanna G, Ren L, Landberg G,
Jirstrom K, Powell C, Borczuk A, Keller ET, Wojno KJ, Meltzer P,
Baird K, McClatchey A, Bretscher A, Hewitt SM and Khanna C:
Expression of the cytoskeleton linker protein ezrin in human
cancers. Clin Exp Metastasis. 24:69–78. 2007.
|
|
10.
|
Hanavadi S, Martin T, Mansel R and Jiang
WG: Interleukin-11 and its receptor expression in human breast
cancer. Ann Surg Oncol. 13:802–808. 2006.
|
|
11.
|
Martin T, Goyal A, Mansel R, Watkins G and
Jiang W: The transcription factor for the E-cadherin complex,
Twist, Slug and Snail, in human breast cancer. Ann Surg Oncol.
12:1–9. 2005.
|
|
12.
|
Jiang WG, Watkins G, Lane J, Cunnick G,
Douglas-Jones A, Mokbel K and Mansel R: Prognostic value of Rho
family and rho-GDIs in breast cancer. Clin Cancer Res. 9:6432–6440.
2003.
|
|
13.
|
Jiang WG, Douglas-Jones A and Mansel R:
Level of expression of PPAR-gamma and its co-activator (PPAR-GCA)
in human breast cancer. Int J Cancer. 106:752–757. 2003.
|
|
14.
|
Nazarenko A, Bhatnagar S and Hohman R: A
closed tube format for amplification and detection of DNA based on
energy transfer. Nucleic Acids Res. 25:2516–2521. 1997.
|
|
15.
|
Parr C, Watkins G and Jiang WG: The
possible correlation of Notch-1 and Notch-2 with clinical outcome
and tumor clinicopathological parameters in human breast cancer.
Int J Mol Med. 14:779–786. 2004.
|
|
16.
|
Jiang WG, Grimshaw D, Lane J, Martin T,
Abounader R, Laterra J and Mansel RE: A hammerhead ribozyme
suppresses expresion of hepatocyte growth factor/scatter factor
receptor c-MET and reduces migration and invasiveness of breast
cancer cells. Clin Cancer Res. 7:2555–2562. 2001.
|
|
17.
|
Ye L, Martin T, Parr C, Harrison G, Mansel
R and Jiang WG: Biphasic effects of 17-β-oestradiol on expression
of occludin and transendothelial resistance and paracellular
permiability in human vascular endothelial cells. J Cell Physiol.
196:362–369. 2003.
|
|
18.
|
King J, Ofori-Acquah SF, Stevens T,
Al-Mehdi A-B, Fodstad O and Jiang WG: Activated leukocyte adhesion
molecule in breast cancer: prognostic indicator. Breast Cancer Res.
6:478–487. 2004.
|
|
19.
|
Davies G, Jiang WG and Mason MD: Cell-cell
adhesion and signalling intermediates in human prostate cancer. J
Urol. 163:985–992. 2000.
|
|
20.
|
Berryman M, Franck Z and Bretscher A:
Ezrin is concentrated in the apical microvilli of a wide variety of
epithelial cells whereas moesin is found primarily in endothelial
cells. J Cell Sci. 105:1025–1043. 1993.
|
|
21.
|
Tsukita S and Hieda Y: A new 82-kD barbed
end-capping protein (radixin) localized in the cell-to-cell
adherens junction: purification and characterization. J Cell Biol.
108:2369–2382. 1989.
|
|
22.
|
Yonemura S and Tsukita S: Direct
involvement of ezrin/radixin/moesin (ERM)-binding membrane proteins
in the organization of microvilli in collaboration with activated
ERM proteins. J Cell Biol. 145:1497–1509. 1999.
|
|
23.
|
Takeuchi K, Sato N, Kasahara H, Funayama
N, Nagafuchi A, Yonemura S and Tsukita S: Perturbation of cell
adhesion and microvilli formation by antisense oligonucleotides to
ERM family members. J Cell Biol. 125:1371–1384. 1994.
|
|
24.
|
Yu Y, Davicioni E, Triche TJ and Merlino
G: The homeo-protein six1 transcriptionally activates multiple
protumorigenic genes but requires ezrin to promote metastasis.
Cancer Res. 66:1982–1989. 2006.
|
|
25.
|
Khanna C, Wan X, Bose S, Cassaday R, Olomu
O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ: The
membrane-cytoskeleton linker ezrin is necessary for osteosarcoma
metastasis. Nat Med. 10:182–186. 2004.
|
